Peptide
Pegvisomant
Pegvisomant is used or studied for reduces igf-1 levels and related growth hormone, recovery and performance goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Detail
Overview
Pegvisomant is used or studied for reduces igf-1 levels and related growth hormone, recovery and performance goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Benefits, side effects, and protocols
Benefits list
- Reduces IGF-1 levels
Side effects
- Liver enzyme elevation
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- High
- Used in acromegaly
Regulatory
- Fda Approved
- Prescription required
Research
Mechanisms
Evidence notes
- High
- Used in acromegaly
Administration
Research links
Contraindications
- None listed
Components
- None listed
Regulatory data
- Fda Approved
- Prescription required
Aliases
- None listed
Related compounds
Half-life
How long does Pegvisomant stay in your system?
Half-life ≈ 60–138 hours — see what remains after any number of days, and when it is practically cleared.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Pegvisomant? Check your source before you use anything.